DOUGLAS DIRUGGIERO: Open Payments
NPI 1730145327 · CARTERSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366,354 in 591 payments from 24 companies in 2025. Trend: 2023 $283,122 · 2024 $396,392 · 2025 $366,354
Speaker / faculty: $210,936Consulting: $89,667Travel & lodging: $51,306Food & beverage: $10,838Honoraria: $3,300Education: $307
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 153 | $83,004 |
| Janssen Biotech, Inc. | 63 | $49,617 |
| Lilly USA, LLC | 57 | $41,590 |
| Arcutis Biotherapeutics, Inc. | 66 | $39,907 |
| ABBVIE INC. | 45 | $30,565 |
| GENZYME CORPORATION | 34 | $30,170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $18,526 |
| Novartis Pharmaceuticals Corporation | 43 | $15,858 |
| UCB, Inc. | 30 | $14,856 |
| Eli Lilly and Company | 13 | $14,624 |
Products named: DUPIXENT, EBGLYSS, TREMFYA, Zoryve, SKYRIZI, SPEVIGO, Bimzelx, OTEZLA.
Industry payments across GA — which companies pay providers there.
